Human melanoma cells, either deficient in or expressing PAF-R, and murine melanoma B16F10 cells, which have been extensively used in chemotherapy studies and lack functional PAF-R expression, were genetically modified to produce cells stably expressing PAF-R or vector-controls as suitable model systems. This evidence concerns the gene PTAFR and melanoma.